Molecularly imprinted therapeutic contact lenses

Expert Opinion on Drug Delivery

Volumn 7, Issue 6, 2010, Pages 765-780

  White, Charles J ^a   Byrne, Mark E ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Anti inflammatory; Antibiotic; Antihistamine; Beta blocker; Combination device; Comfort molecule; Contact lens; Controlled release; Drug delivery; Macromolecular memory; Molecular imprinting; Ophthalmology

Indexed keywords

DICLOFENAC; HYALURONIC ACID; KETOTIFEN FUMARATE; NORFLOXACIN; TIMOLOL;

ALLERGIC CONJUNCTIVITIS; BIOMIMETICS; COMPLEX FORMATION; CONTACT LENS; CONTROLLED DRUG RELEASE; CROSS LINKING; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DIFFUSION; DRUG PENETRATION; DRUG TRANSPORT; EXTENDED WEAR CONTACT LENS; GLAUCOMA; HUMAN; HYDROGEL; MEAN RESIDENCE TIME; MICROFLUIDICS; MOLECULAR IMPRINTING; POLYMERIZATION; RECOMMENDED DRUG DOSE; REVIEW; SOFT CONTACT LENS; WATER CONTENT;

CONTACT LENSES; DRUG ADMINISTRATION ROUTES; HYDROGELS;

EID: 77952678353     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425241003770098     Document Type: Review

References (105)

1. Wichterle O, Lim D. Cross-linked hydrophilic polymers and articles made therefrom. US patent: 3220960; 1965
2. Wichterle O, Lim D. Hydrophilic gels for biological use. Nature 1960;185:117-118
3. Wichterle O, Lim D. Process for producing shaped articles from three-dimensional hydrophilic high polymer. US patent: 2976576; 1961
4. Sedlavek J. Possibilities of application of eye drugs with the aid of gel-contact lenses. Cesk Slov Oftalmol 1965;21:509-512
5. Arrington G. A history of ophthalmology. MD Publications, New York; 1959
6. Albert D. History of ophthalmology. Blackwell Sciences, Inc., Cambridge; 1996
7. Hirchberg R. The history of ophthalmology. Volume 1. Antiquity. Translated by Frederick Blodi. Kugler Publications, Bonn; 1982
8. Karlgard C, Wong N, Jones L, Moresoli C. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int J Pharm 2003;257:141-151
9. Kapoor Y, Thomas J, Tan G, et al. Surfactant laden soft contact lenses for extended delivery of ophthalmic drugs. Biomaterials 2009;30:867-878
10. Li C, Abrahamson M, Kapoor Y, Chauhan A. Timolol transport from microemulsions trapped in HEMA gels. J Colloid Interface Sci 2007;315:297-306
11. Gulsen D, Li C, Chauhan A. Dispersion of DPMC liposomes in contact lenses for ophthalmic drugs. Curr Eye Res 2005;30(12):1071-1080
12. Gulsen D, Chauhan A. Ophthalmic drug delivery through contact lenses. Invest Ophthalmol Vis Sci 2004;45:2342-2347
13. Uchida R, Sato T, Tanigawa H, Uno K. Azulene incorporation and release by hydrogel containing methacrylamide propyltrimethylammonium chloride and its application to soft contact lens. J Control Release 2003;92(3):259-264
14. Sato T, Uchida R, Tanigawa H, et al. Application of polymer gels containing side-chain phosphate groups to drug-delivery contact lenses. J Control Release 2003;92(3):259-264
15. Byrne M, Salian V. Molecular imprinting within hydrogels II: progress and analysis of the field. Int J Pharm 2008;364(2):188-212
16. Byrne M, Park K, Peppas N. Molecular imprinting within hydrogels. Adv Drug Deliv Rev 2002;54(1):149-161
17. Ali M, Byrne M. Challenges and solutions in topical ocular drug-delivery systems. Expert Rev Clin Pharmacol 2008;1(1):145-161
18. Vandamme TF. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog Retin Eye Res 2002;21:15-34
19. Zurowska-Pryczkowska K, Sznitsowska M, Janicki S. Studies on the effect of pilocarpine incorporation into a submicron emulsion on the stability of the drug and the vehicle. Eur J Pharm Biopharm 1999;47(3):255-260 (Pubitemid 29257884)
20. Naveh N, Muchtar A, Benita S. Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged ocular hypotensive effect in rabbits. J Ocul Pharmacol 1994;10(3):15-34
21. Fialho S, da Silva-Cunha A. New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin Exp Ophthalmol 2004;32(6):626-632
22. Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev 1995;16:61-73
23. Mainardes R, Urban M, Cinto P, et al. Colloidal carriers for ophthalmic drug delivery. Curr Drug Targets 2005;6(3):363-371
24. Pignatello R, Bucolo C, Ferrara P, et al. RS100- Nanosuspensions for the ophthalmic conrolled delivery of ibuprofen. Eur J Pharm Sci 2002;16(1-2):53-61
25. Kassem M, Abdel Rahman A, Ghorab M, et al. Nanosuspension as an ophthalmic delivery systems for certain glucocorticoid drugs. Int J Pharm 2007;340(1-2):126-133
26. Ebrahim S, Peyman G, Lee P. Applications of liposomes in ophthalmology. Surv Ophthalmol 2005;50(2):167-182
27. Ticho U, Blumenthal M, Zonis S, et al. Piloplex, a new long acting pilocarpine polymer salt. A: long-term study. Br J Ophthalmol 1979;63:45-47
28. Mazor Z, Ticho U, Rehany U, Rose L. Piloplex, a new long acting pilocarpine polymer salt. B: comparative study of the visual effects of pilocarpine and piloplex eye drops. Br J Ophthalmol 1979;63:58-61
29. Maurice D. Prolonged-action drops. Int Ophthalmol Clin 1993;33:81-91
30. Bernkop-Schnerch A. Thiomers: a new generation of mucoadhesive polymers. Adv Drug Deliv Rev 2005;57(11):1569-1582
31. Hornof M, Weyenberg W, Ludwig A, Bernkop-Schnurch A. Mucoadhesive ocular insert based on thiolated poly (acrylic acid): development and in vivo evaluation in humans. J Control Release 2003;89(3):419-428
32. Aggarwal D, Kaur I. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharmacol 2005;290(1-2):155-159
33. Greaves J, Wilson C. Treatment of diseases of the eye with mucoadhesive delivery systems. Adv Drug Deliv Rev 1993;11(3):349-383
34. Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 2005:57(11):1595-1639
35. Lin H, Sung K. Carbopol/pluronic phase change solution for ophthalmic drug delivery. J Control Release 2000;69:379-388
36. Sultana Y, Aqil M, Ali A, Zafar S. Evaluation of carbopol-methyl cellulose based sustained-release ocular delivery system for pefloxacin mesylate using rabbit eye model. Pharm Dev Technol 2006;11(3):313-319
37. Rozier A, Mazuel C, Grove J, Plazonnet B. Gelrite-: a novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. Int J Pharmacol 1989;57(2):163-168
38. Sultana Y, Aqil M, Ali A. Ion-activated Gelrite--based in situ ophthalmic gels of perfloxacin mesylate: comparison with conventional eye drops. Drug Deliv 2006;13(3):215-219
39. Tai M, Cosar C, Cohen E, et al. Clinical efficacy of silicone punctal plug therapy. Cornea 2002;21(2):135-139
40. Balaram M, Schaumberg D, Dana M. Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome. Am J Ophthalmol 2001;131(1):30-36 (Pubitemid 32037005)
41. Willis RM, Folberg R, Krachmer JH, Holland EJ. Treatment of aqueous-deficient dry eye with removable punctal plugs. A clinical and impression-cytologic study. Ophthalmology 1987;94(5):514-518
42. Lang J. Ocular drug delivery: conventional ocular formulations. Adv Drug Deliv Rev 1995;16(1):39-43
43. Geroski D, Edelhauser H. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci 2000;41(5):961-964
44. Clark A, Yorio T. Ophthalmic drug discovery. Nat Rev Drug Discov 2003;2(6):446-459
45. Ghate D, Edelhauser H. Ocular drug delivery. Expert Opin Drug Deliv 2006;3(2):275-287
46. Le Bourlais C, Acar L, Zia H, et al. Ophthalmic drug delivery systems: recent advances. Prog Retin Eye Res 1998;1:33-58
47. Saettone M. Progress and problems in ophthalmic drug delivery. Pharmatech 2002:1-6
48. Schoenwald R. Ocular pharmacokinetics. In: Zimmerman T, Kooner K, Sharir M, et al., editors, Textbook of ocular pharmacology. Lippincott-Raven Publishers, Pennsylvania; 1997. p. 119-139
49. Bartlett J, Jaanus S. Clinical ocular pharmacology. Butterworth-Heinemann Publishers, Massachusetts; 1984
50. Glasson M, Stapleton F, Keay L, Willcox M. The effect of short term contact lens wear on the tear film and ocular surface characteristics of tolerant and intolerant wearers. Contact Lens Anterior Eye 2006;29(1):41-47
51. Doane M. Blinking and the mechanics of the lacrimal drainage system. Ophthalmology 1981;88(8):844-851
52. Sharma A, Ruckenstein E. Mechanism of tear film rupture and its implications for contact lens tolerance. Am J Optom Physiol Opt 1985;62(2):246-253
53. Sklubalova Z, Zatloukal Z. Systemic study of factors affecting eye drop size and dosing variability. Pharmazie 2005;60(12):917-921
54. Peppas N. Hydrogels in medicine and pharmacy. Volume I: Fundamentals. CRC Press, Boca Raton; 1987
55. Hilt J, Byrne M. Configurational biomimiesis in drug delivery: molecular imprinting of biologically significant molecules. Adv Drug Deliv Rev 2004;56:1599-1620
56. Ge Y, Turner A. Too large to fit-Recent developments in macromolecular imprinting. Trends Biotechnol 2008;29:89-104
57. Hillberg A, Tabrizian M. Biomolecule imprinting: developments in mimicking dynamic natural recognition systems. ITBM RBM 2008;29:89-104
58. Bergmann N, Peppas N. Molecularly imprinted polymers with specific recognition for macromolecules and proteins. Prog Polym Sci 2008;33:271-288
59. Wei S, Jakusch M, Mizaikoff B. Capturing molecules with templated materials -- analysis and rational design of molecularly imprinted polymers. Anal Chim Acta 2006;578:50-58
60. Zhang H, Ye L, Mosbach K. Non-covalent molecular imprinting with emphasis on its application in separation and drug development. J Mol Recognit 2006;19:248-259
61. Janiak D, Kofinas P. Molecular imprinting of peptides and proteins in aqueous media. Anal Bioanal Chem 2007;389:399-404
62. Bossi A, Bonini F, Turner A, Piletsky S. Molecularly imprinted polymers for the recognition of proteins: state of the art. Biosens Bioelectron 2007;22(6):1131-1137
63. Turner N, Jeans C, Brain K, et al. From 3D to 2D: a review of the molecular imprinting of proteins. Biotechnol Prog 2006;22(6):1474-1489
64. Ye L, Mosbach K. Molecular imprinting: synthetic materials as substitutes for biological antibodies and receptors. Chem Mater 2008;20:859-868
65. Wulff G. Enzyme-like catalysis by molecularly imprinted polymers. Chem Rev 2002;102:1-27
66. Mayes A, Whitecombe M. Synthetic strategies for the generation of molecularly imprinted organic polymers. Adv Drug Deliv Rev 2005;57:1742-1778
67. Wei S, Mizaikoff B. Recent advanced on noncovalent molecular imprints for affinity separations. J Sep Sci 2007;30:1794-1805
68. Whitcombe M, Vulfson E. Imprinted polymers. Adv Mater 2001;13:467-478
69. Alexander C, Andersson H, Andersson L, et al. Molecular imprinting science and technology: a survey of the literature for the years up to and including 2003. J Mol Recognit 2006;19:106-180
70. Davis M, Katz A, Ahmad W. Rational catalyst design via imprinted nanostructured materials. Chem Mater 1996;8:1820-1839
71. Alvarez-Lorenzo C, Concheiro A. Molecularly imprinted polymers for drug delivery. J Chromatogr B 2004;804:231-245
72. Sellergen B, Allender C. Molecularly imprinted polymers: a bridge to advanced drug delivery. Adv Drug Deliv Rev 2005;57:1733-1741
73. Allender C, Richardson C, Woodhouse B, et al. Pharmaceutical applications for molecularly imprinted polymers. Int J Pharmacol 2000;195:39-43
74. Cunliffe D, Kirby A, Alexander C. Molecularly imprinted drug delivery systems. Adv Drug Deliv Rev 2005;57:1836-1853
75. Brazel C, Peppas N. Modeling of drug release from swellable polymers. Eur J Pharm Biopharm 2000;49:47-58
76. Tahara K, Yamato K, Nishihata T. Overall mechanism behind matrix sustained release tablets prepared with hydroxypropyl methylcellulose 2910. J Control Release 1995;35:59-66
77. Lee E, Kim S, Cardinal J, Jacobs H. Drug release from hydrogel devices with rate controlling barriers. J Membr Sci 1980;7:293-303
78. Lee P. Novel approach to zero order drug delivery via immobilized non-uniform drug distribution in glassy hydrogels. J Pharm Sci 1984;7:1344-1347
79. Alvarez-Lorenzo C, Hiratani H, Concheiro A. Contact lenses for drug delivery: achieving sustained release with novel systems. Am J Drug Deliv 2006;4(3):131-151
80. Alvarez-Lorenzo C, Hiratani H, Gomez-Amoza JL, et al. Soft contact lenses capable of sustained delivery of timolol. J Pharam Sci 2002;91(10):2182-2192
81. Friedman DS, Congdon N, Kempen J, Tielsch JM. Vision Problems in the U.S.: Prevalence of Adult Vision Impairment and Age-Related Eye Disease in America, National Eye Institute and Prevent Blindness America, (2002). Available from: http://www.nei.nih.gov/eyedata/ [Accessed 1 July 2007]
82. National Eye Inst. Progress in Eye and Vision Research 1999-2006, National Institute of Health, US Department of Health and Human Services; 2006
83. Timoptic,Sterile Ophthalmic Solution Prescription Information. Merck & Co., Inc.; September 2005
84. Hiratani H, Alvarez-Lorenzo C. Timolol uptake and release by imprinted soft contact lenses made of N, N-diethylacrylamide and methacrylic acid. J Control Release 2002;83(2):223-230
85. Hiratani H, Alvarez-Lorenzo C. The nature of backbone monomer determines the performance of imprinted soft contact lenses as timolol drug delivery systems. Biomaterials 2004;25(6):1105-1113
86. Hiratani H, Mizutani Y, Alvarez-Lorenzo C. Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities. Macromol Biosci 2005;5(8):728-733
87. Alvarez-Lorenzo C, Yanez F, Barreiro-Iglesias R, Concheiro A. Imprinted soft contact lenses as norfloxacin delivery systems. J Control Release 2006;113:236-244
88. Venkatesh S, Sizemore S, Zhang J, Byrne M. Therapeutic contact releases: a biomimetic approach towards tailored ophthalmic extended delivery. Polym Mater Sci Eng Preprints 2006;94:766-767
89. Venkatesh S, Sizemore S, Byrne M. Biomimetic hydrogels for enhanced loading and extended release of ocular therapeutics. Biomaterials 2007;28:717-724
90. Meot-Ner M. The ionic hydrogen bond. Chem Rev 2005;105:213-284
91. Lodish H, Berk A, Zipursky L, et al. Molecular cell biology. Section 2.2. Noncovalent Bonds. W.H. Freeman and Co, New York; 2000
92. Venkatesh V, Saha J, Pass S, Byrne M. Transport and structural analysis of molecularly imprinted hydrogels for controlled drug delivery. Eur J Pharm Biopharm 2008;69:852-860
93. Zaditor Prescribing Information, Novartis Ophthalmics, 24 March 2006
94. Zaditor Website. Available from: http:// www.zaditor.com/info/about/ zaditor-eye-drops.jsp [Accessed 1 February 2010]
95. Warner JO, Kaliner MA, Crisci CD, et al. Allergy practice worldwide: a report by the World Allergy Organization Specialty and Training Council. Int Arch Allergy Immunol 2006;139(2):166-174
96. Ali M, Horikawa S, Venkatesh S, et al. Zero-order therapeutic release from imprinted hydrogel contact lenses within in-vitro physiological ocular tear flow. J Control Release 2007;124:154-162
97. Ali M. Therapeutic contact lenses for comfort molecules, Master's Thesis. Auburn University; 2007
98. Ali M, Byrne M. Controlled release of high molecular weight hyaluronic acid from molecularly imprinted hydrogel contact lenses. Pharm Res 2009;26(3):714-726
99. Vaughan A, Zhang J, Byrne M. Enhancing therapeutic loading and delaying transport via molecular imprinting and living/controlled polymerization. AICHE J 2010;56(1):268-279
100. Gomes J, Amankwah R, Powell-Richards A, Dua H. Sodium hyaluronate (Hyaluronic Acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol 2004;88:821-825
101. Hiratani H, Fujiwara A, Tamiya Y, Alvarez-Lorenzo C. Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials 2005;26(11):1293-1298
102. Morgan P, Woods C, Tranoudis I, et al. International contact lens prescribing in 2009. Cont Lens Spectr 2010;53:30-35
103. Prausnitz M, Noonan J. Permeability of cornea, sclera, and conjuctiva: a literature analysis for drug delivery to the eye. J Pharm Sci 1998;87(12):1479-1488
104. Drug facts and comparisions. J.B. Lippincott Co, St Louis, Mo; 1991
105. Drug evaluations subscription. American Medical Association; Spring, Chicago, Ill; 1990